Background: Programmed death-ligand 1 (PD-L1) checkpoint inhibitors represent a mainstay of therapy in head and neck squamous cell cancer (HNSCC). However, little is known about the influence of combined therapy on PD-L1 expression. The study aims to gather evidence on this topic. Methods: A systematic search was carried out in electronic databases Pubmed-MEDLINE and Embase to retrieve studies on the comparison of PD-L1 expression before and after conventional therapy. Data were extracted and a quantitative analysis with pooled odds ratios (ORs) was performed when applicable. Results: Of 5688 items, 15 were finally included. Only a minority of studies assessed PD-L1 with the recommended combined positive score (CPS). The results are highly heterogeneous, with some studies reporting an increase in PD-L1 expression and others reporting a decrease. Three studies allowed for quantitative analysis and showed a pooled OR of 0.49 (CI 0.27-0.90). Conclusions: From the present evidence, a clear conclusion towards an increase or decrease in PD-L1 expression after combined therapy cannot be drawn, but even with few studies available, a trend towards an increase in expression in tumor cells at a cutoff of 1% can be noted in patients undergoing platinum-based therapy. Future studies will provide more robust data on the effect of combined therapy on PD-L1 expression.

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma / Girolami, Ilaria; Marletta, Stefano; Fiorentino, Vincenzo; Battocchio, Simonetta; Cerbelli, Bruna; Fiamengo, Barbara; Gerosa, Clara; Gianatti, Andrea; Morelli, Luca; Riva, Giulio; Zagami, Maria Giovanna; Fusco, Nicola; Munari, Enrico; L'Imperio, Vincenzo; Pagni, Fabio; Morbini, Patrizia; Martini, Maurizio; Eccher, Albino. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:2(2023), pp. 1-12. [10.3390/jpm13020363]

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma

Eccher, Albino
2023

Abstract

Background: Programmed death-ligand 1 (PD-L1) checkpoint inhibitors represent a mainstay of therapy in head and neck squamous cell cancer (HNSCC). However, little is known about the influence of combined therapy on PD-L1 expression. The study aims to gather evidence on this topic. Methods: A systematic search was carried out in electronic databases Pubmed-MEDLINE and Embase to retrieve studies on the comparison of PD-L1 expression before and after conventional therapy. Data were extracted and a quantitative analysis with pooled odds ratios (ORs) was performed when applicable. Results: Of 5688 items, 15 were finally included. Only a minority of studies assessed PD-L1 with the recommended combined positive score (CPS). The results are highly heterogeneous, with some studies reporting an increase in PD-L1 expression and others reporting a decrease. Three studies allowed for quantitative analysis and showed a pooled OR of 0.49 (CI 0.27-0.90). Conclusions: From the present evidence, a clear conclusion towards an increase or decrease in PD-L1 expression after combined therapy cannot be drawn, but even with few studies available, a trend towards an increase in expression in tumor cells at a cutoff of 1% can be noted in patients undergoing platinum-based therapy. Future studies will provide more robust data on the effect of combined therapy on PD-L1 expression.
2023
13
2
1
12
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma / Girolami, Ilaria; Marletta, Stefano; Fiorentino, Vincenzo; Battocchio, Simonetta; Cerbelli, Bruna; Fiamengo, Barbara; Gerosa, Clara; Gianatti, Andrea; Morelli, Luca; Riva, Giulio; Zagami, Maria Giovanna; Fusco, Nicola; Munari, Enrico; L'Imperio, Vincenzo; Pagni, Fabio; Morbini, Patrizia; Martini, Maurizio; Eccher, Albino. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:2(2023), pp. 1-12. [10.3390/jpm13020363]
Girolami, Ilaria; Marletta, Stefano; Fiorentino, Vincenzo; Battocchio, Simonetta; Cerbelli, Bruna; Fiamengo, Barbara; Gerosa, Clara; Gianatti, Andrea;...espandi
File in questo prodotto:
File Dimensione Formato  
jpm-13-00363.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 684.09 kB
Formato Adobe PDF
684.09 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1317413
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact